Showing 3851-3860 of 21443 results for "".
- Melanoma Rates Among Non-Hispanic American Indian/Alaska Natives Vary by Age, Region: Studyhttps://reachmd.com/news/melanoma-rates-among-non-hispanic-american-indianalaska-native-individuals/2462199/A new study in JAMA Dermatology shed light on trends and incidence rates of invasive cutaneous melanoma in non-Hispanic American Indian/Alaska Native individuals. The cross-sectional observational study, focusing on a period from 1999 to 2019, included data drawn from a populati
- Suggestions from American Gastroenterological Association Roundtable Meeting on Improving IBD Clinical Trial Designhttps://reachmd.com/news/suggestions-from-american-gastroenterological-association-roundtable-meeting-on-improving-ibd-clinical-trial-design/2456713/The American Gastroenterological Association (AGA) recently published a summary of their roundtable meeting discussing current challenges and potential solutions for impr
- Potent and Highly Selective CDK9 Inhibitor for Treatment of Hematologic Malignancieshttps://reachmd.com/news/potent-and-highly-selective-cdk9-inhibitor-for-treatment-of-hematologic-malignancies/2456717/by Impact Journals LLC Effe
- Upadacitinib Linked with Improvement for Hand Eczema in Patients with Atopic Dermatitishttps://reachmd.com/news/updacitinib-shows-promise-for-ad-and-hand-eczema-in-trial/2462198/Results from a new study suggest that upadacitinib is efficacious for the treatment of hand eczema (HE) and atopic dermatitis (AD) in patients with AD. The study authors, publishing in Contact Dermatitis, included a total of 38 patients in the observational cohort analysis (32 of
- Fractional COVID-19 Booster Vaccines Produce Similar Immune Response as Full-Doseshttps://reachmd.com/news/fractional-covid-19-booster-vaccines-produce-similar-immune-response-as-full-doses/2456705/Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study. The research, led by Murdoch Children's Research Institute (MCRI) and the National Centre for Communicable D
- 187 New Genetic Variants Linked to Prostate Cancer Found in Largest, Most Diverse Study of Its Kindhttps://reachmd.com/news/187-new-genetic-variants-linked-to-prostate-cancer-found-in-largest-most-diverse-study-of-its-kind/2456691/A globe-spanning scientific team has compiled the most comprehensive list of genetic variants associated with prostate cancer risk — 451 in all — through a whole-genome analysis that ranks as the largest and most diverse investigation into prostate cancer genetics yet. The research, led by the
- Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Methttps://reachmd.com/news/microbot-medical-announced-positive-results-of-its-glp-pivotal-pre-clinical-study-where-all-study-objectives-were-met/2456694/BRAINTREE, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces the successful completion of its GLP pivotal pre-clinical study, done under
- New Doctors Just Aren't That Interested in Geriatricshttps://reachmd.com/news/new-doctors-just-arent-that-interested-in-geriatrics/2456712/Doctors specializing in care for older adults are increasingly in demand as the country
- Early Indicators of Multiple Sclerosis Evident 5 Years Before Diagnosis, Reveals Recent Studyhttps://reachmd.com/news/early-indicators-of-multiple-sclerosis-evident-5-years-before-diagnosis-reveals-recent-study/2456696/A recent study has revealed five early symptoms of multiple sclerosis that can be identified five years prior to the diagnosis. According to Mayo Clinic, “Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system).
- New Studies Inform Best Practices for Pelvic Organ Prolapsehttps://reachmd.com/news/new-studies-inform-best-practices-for-pelvic-organ-prolapse/2456699/For patients with uterine prolapse, a traditional technique showed superiority, while vaginal estrogen cream failed to improve outcomes for vaginal apical prolapse repair in two new studies published in JAMA.“Approximately one in five women will undergo surg